China’s patent prosecution and enforcement landscape has been transformed over the past decade. At the regulatory level, the Patent Law has undergone sweeping amendments, accompanied by a cascade of implementing rules, administrative measures, and judicial interpretations that have recalibrated core doctrines, procedures, and remedies. Institutionally, the system has continued to professionalize: specialized intellectual property (IP) courts and tribunals have expanded, and the former State Intellectual Property Office (SIPO) has been reorganized into the China National Intellectual Property Administration (CNIPA), reshaping examination and administrative enforcement practice. Substantively, new frontiers have moved to center stage, from standard-essential patents and FRAND licensing—often with cross-border implications—to the challenges posed by artificial intelligence for inventorship, disclosure, and patentable subject matter. Meanwhile, a rapidly growing body of patent and IP case law is providing clearer guidance on evidence, injunctions, damages (including punitive damages), and the interplay between administrative adjudication and civil litigation.
Against this backdrop, this seminar convenes leading experts to distill and discuss the latest developments in patent law across Greater China. Topics will include cutting-edge issues in patent enforcement and remedies, and sector-specific insights, with particular attention to the pharmaceutical and gaming industries. Participants will gain practical takeaways on strategy, risk, and compliance in a regime that is maturing swiftly and setting important markers for global IP practice.
About the Speakers:

0 Comments